In an interview with OncLive in September, 2020, Dr. Treon from DFCI discussed the various BTK inhibitors that are now available or in trials.
Along the same lines, a very valuable discussion was moderated by Dr. Treon, including experts from Europe and Australia. This was recorded for the Oncology Learning Network in 2019.
It is available as both a video and as a transcript.